Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Modified lipid nanoparticles deliver mRNA vaccines to lymph nodes more effectively, reducing liver accumulation.
Penn engineers have developed modified lipid nanoparticles that deliver mRNA vaccines more effectively to lymph nodes while reducing liver accumulation.
In animal models, these aroLNPs maintained strong immune responses while delivering at least tenfold less mRNA to the liver than the Moderna vaccine formulation, potentially allowing for lower doses and fewer side effects.
This technology could improve future mRNA therapies for cancer and autoimmune diseases.
3 Articles
Las nanopartículas lipídicas modificadas entregan vacunas de ARNm a los ganglios linfáticos de manera más efectiva, reduciendo la acumulación en el hígado.